Skip to content

PHARMACIE DEFRE

Active Private limited companyfounded 2003active for 23 yearsPlace de Velaines 13, 7760 Celles (lez-Tournai)KBO/BCE: BE 0480.024.492 subsidiary of #6 company by equity in Celles, Wholesale and retail trade sector

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak of €376,090 in 2022
€350,376▲ 15.3%
lowest -€79,249 in 2015
€72,183▲ 23.0%
peak of €353,809 in 2025
€353,809▲ 6.7%
€803,243▼ 2.0%
peak of 3.2 FTE in 2012
2.3 FTEunchanged
Board3 names since 2014
1 director
Owners
  
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €303,812 to €350,376Cash from €33,682 to €83,207

Key points

from the 2025 annual accounts

Equity

€353,809 ▲ 6.7%

PHARMACIE DEFRE has made a profit without a break since 2017.

Turnover

≈ €1.2m estimated

The accounts state no turnover.

Filings

23 annual accounts since 2003
AprilJune31 JulyOctober20102020

Ten of the last ten came late. The 2018 accounts came in latest, 188 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as PHARMACIE DEFRE has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for PHARMACIE DEFRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 30-09-2022
  • 100%score equity €192,983 (2025) · annual accounts 2025 of

Shares in 2 companies, and

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0480024492
appointed as director acts as permanent representative · “Toutes activités de conseils en matière de marketing, merchandising, aménagement, communication, management et…” (deed in French) · Director discharge: (manager) · General meeting of 28-12-2023 · Gazette deed
1 director appointed, 1 resignation resigns · appointed · acts as permanent representative · General meeting of 30-09-2022 · Gazette deed
Capital increase of €31,400 to €50,000 The capital rose from €18,600 to €50,000 · acts as permanent representative · General meeting of 12-04-2016 · Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACIE DEFRE Celles (lez-Tournai) €1.2m €350,376 30.6% 2.3
PHARMACIE STASSEN-BYA Juprelle €1.2m €352,351 49.4% 2.4
APOTHEEK TAKOFARMA Aarschot €1.2m €325,995 59.8% 2.1
PHARMACIE ERGO Estinnes €1.3m €309,919 66.4% 2.7
Apotheek Wijchmaal Peer €1.2m €332,635 29.9% 2.7
PHARMALIS Neufchâteau €1.1m €336,675 7.8% 1.9
APOTHEEK DENYS ZANDHOVEN Zandhoven €1.2m €397,159 76.9% 2.6

These companies have the same main activity as PHARMACIE DEFRE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 2000 and 2005.

Official details

Source: KBO
Status
Active since 14-04-2003Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.131.765.0401180 Uccle, since 16-05-2003
Financial year end
31 December
Peppol
Reachable since 20-10-2025
Company details

Annual accounts 2025

€1.2m▲ 0.5%
Employeeson 31-12-2025
3=
Filing
Filed on 31-08-2026
Financials

Insights on PHARMACIE DEFRE

PHARMACIE DEFRE files the abbreviated format. That format states no turnover. The gross margin rose from €99,854 in 2006 to €350,376 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACIE DEFRE

What is the company number of PHARMACIE DEFRE?
The company number of PHARMACIE DEFRE is 0480.024.492. The VAT number is the same number with BE in front: BE 0480.024.492.
Where is PHARMACIE DEFRE based?
The registered office is at Place de Velaines 13, 7760 Celles (lez-Tournai).Company details
What does PHARMACIE DEFRE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE DEFRE?
PHARMACIE DEFRE is a private limited company (BV).
When was PHARMACIE DEFRE founded?
PHARMACIE DEFRE was founded on 14-04-2003.
Is PHARMACIE DEFRE still active?
Yes, PHARMACIE DEFRE is an active enterprise in the KBO register.
How many employees does PHARMACIE DEFRE have?
PHARMACIE DEFRE had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE DEFRE?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €350,376 and 42 comparable companies (NACE 477). It probably lies between €950,000 and €1.7m. In financial year 2018 turnover was €1.2m.
Is PHARMACIE DEFRE profitable?
In financial year 2025, PHARMACIE DEFRE made a profit of €72,183.
Where can I find the annual accounts of PHARMACIE DEFRE?
PHARMACIE DEFRE filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE DEFRE due?
PHARMACIE DEFRE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.